Medicines Control Authority of Zimbabwe

Background

Medicines Control Authority of Zimbabwe (MCAZ) is a statutory body established by an Act of Parliament.

The Medicines and Allied Substances Control Act (MASCA) [Chapter 15.03]. MCAZ is a successor of the Drugs Control Council (DCC) and the Zimbabwe Regional Drug Control Laboratory (ZRDCL). DCC was established by an Act of Parliament in 1969: Drugs and Allied Substances Control Act [Chapter 15.03] following which ZRDCL became operational in 1989.

Richard Rukwata – MCAZ Director General

MCAZ Core Business

Medicines Control Authority of Zimbabwe (MCAZ) is responsible for protecting public and animal health by ensuring that accessible medicines and allied substances and medical devices are safe, effective and of good quality through enforcement of adherence to standards by manufacturers and distributors. The mandate of MCAZ is to protect public health ensuring that medicines and medical devices on the market are safe, effective and of good quality.

Mission Statement

To ensure access to safe, effective and good quality medical products and allied substances for the protection of public and animal health.

Credo

Protecting your right to quality medicines and medical devices.

Vision

To be an effective and efficient regulator for medical products and allied substances in Zimbabwe, and a comparative regulator globally.

Values

Customer focus: Being reliable, responsive to needs, communicating and creating a conducive working environment.

Integrity: Being ethical, professional, objective, honest and adhering to moral values.

Continuous improvement: Being proactive, dynamic, and adaptive in all we do.

Accountability: Taking full responsibility for our actions.

Innovation: Being innovative in our problem solving.

Teamwork: Being collaborative, working together as one in pursuit of defined outcomes.

Accolades

WHO Global Benchmarking Maturity Level 3

ISO 9001:2015 accreditation

WHO Prequalification of Chemistry Labs

ISO 17025:2017 accreditation by SADCAS.

To ensure access to safe, effective and good quality medical products and allied substances for the protection of public and animal health.

Related Posts

Tryson Chimbetu opens up on drug ordeal . . . commends First Lady’s fight against substance abuse

Takawira Dapi Herald Correspondent Second-generation Dendera musician Tryson Chimbetu has opened up about his painful battle with drug and substance abuse, crediting First Lady Dr Auxillia Mnangagwa for inspiring his…

Call for balanced approach on Zim’s route-to-market levy

Nelson Gahadza Business Reporter ECONOMIC and tax experts say Zimbabwe’s Route to Market Levy, introduced in 2024 under Section 81A of the Value Added Tax Act, has gone some way…

Leave a Reply

Your email address will not be published. Required fields are marked *

×
×